02262017Headline:

Southeast Pennsylvania, Pennsylvania

HomePennsylvaniaSoutheast Pennsylvania

    Heading
    • Potential Consolidation of Farxiga Cases Highlights Growing Risk

      Potential Consolidation of Farxiga Cases Highlights Growing Risk

      Earlier this month, Plaintiffs with current litigation against AstraZeneca and Bristol-Myers Squibb for injuries related to their SGLT2 diabetes drug, Farxiga, petitioned the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate their cases in the U.S. District Court of […]

    • More Trials Set for J&J’s Risperdal Despite Latest Settlement

      More Trials Set for J&J’s Risperdal Despite Latest Settlement

      Lawsuits against Johnson & Johnson (J&J) continued to increase in 2016, with new complaints filed over a mix of household items, drugs, and medical devices including Johnson’s Baby Powder, the DePuy and Pinnacle hip implants, the blood thinner Xarelto, and […]

    • The Latest on Takata: Are You Protecting Yourself from Purchasing an Unsafe Vehicle?

      The Latest on Takata: Are You Protecting Yourself from Purchasing an Unsafe Vehicle?

      This week has seen the Takata airbag story resurface in national news, as the number of affected vehicles has inflated yet again. Automaker Toyota recently announced that they would add another 543,000 vehicles to the U.S. recall, while Ford and […]

    • Bayer Fails to Change

      Bayer Fails to Change

      On Thursday, December 29th, a petition was filed requesting that the Judicial Panel on Multidistrict Litigation (JPML) create a single docket for more than 100 lawsuits against the contraceptive device Mirena—all claiming that use of the product has resulted in […]

    • Consumers Suffer as Abilify Legal Woes Continue

      Consumers Suffer as Abilify Legal Woes Continue

      While those who suffer from schizophrenia, bipolar disorder, depression and other mental disorders might be familiar with Bristol-Meyers Squibb’s top-selling drug, Abilify (aripiprazole), they might not be aware of the ongoing controversy that has the pharmaceutical giant headed to court […]

    • As Damages Multiply, Is J&J Getting the Message?

      As Damages Multiply, Is J&J Getting the Message?

      Recently, a federal jury in Dallas, Texas ordered Johnson & Johnson and its subsidiary, DePuy Orthopaedics, to pay more than $1 billion to six plaintiffs in the third bellwether trial of a multidistrict litigation (MDL) over the DePuy Pinnacle artificial […]

    • MDL May Be on the Horizon for Hernia Mesh Lawsuits

      MDL May Be on the Horizon for Hernia Mesh Lawsuits

      On December 1st, the U.S. Judicial Panel on Multidistrict Litigation (JPML) began hearing oral arguments on the consolidation of at least 15 lawsuits filed by patients who have suffered alleged injuries resulting from the use of C-Qur polypropylene surgical mesh—an […]

    • Plaintiffs Seek MDL for PPI Lawsuits

      Plaintiffs Seek MDL for PPI Lawsuits

      On October 17th, Plaintiff’s filed a motion for transfer with the U.S. Judicial Panel for Multidistrict Litigation (JPML) in an attempt to consolidate numerous lawsuits regarding kidney damage from the use of proton pump inhibitors (PPIs). PPIs include popular prescription […]

    • Several Studies Focus on Risks of Fluoroquinolones

      Several Studies Focus on Risks of Fluoroquinolones

      A recent study by the Journal of the American Medical Association (JAMA) concluded that one out of three people with a sinus infection, sore throat or earache is prescribed the wrong antibiotic. Most people probably prefer better odds. Perhaps even […]

    • Do PDE5 Inhibitors Cause Skin Cancer?

      Do PDE5 Inhibitors Cause Skin Cancer?

      According to recent lawsuits, many believe the answer is yes. More commonly known as erectile dysfunction drugs, PDE5 inhibitors—so named because they block a specific enzyme that can cause restricted blood flow in certain muscle tissue—have been associated with an […]